{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:39:10Z","timestamp":1792975150878,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T00:00:00Z","timestamp":1349222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00467-012-2310-x","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T08:10:17Z","timestamp":1349165417000},"page":"415-426","source":"Crossref","is-referenced-by-count":222,"title":["Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO"],"prefix":"10.1007","volume":"28","author":[{"given":"Rebecca M.","family":"Lombel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie S.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,3]]},"reference":[{"key":"2310_CR1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16:1040\u20131044","journal-title":"Pediatr Nephrol"},{"key":"2310_CR2","doi-asserted-by":"crossref","unstructured":"International Study of Kidney Disease in Children (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 20:765\u2013771","DOI":"10.1038\/ki.1981.209"},{"key":"2310_CR3","first-page":"203","volume":"45","author":"A Bagga","year":"2008","unstructured":"Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M (2008) Management of steroid-sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 45:203\u2013214","journal-title":"Indian Pediatr"},{"key":"2310_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","volume":"124","author":"DS Gipson","year":"2009","unstructured":"Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747\u2013757","journal-title":"Pediatrics"},{"key":"2310_CR5","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2008) Syndrome n\u00e9phrotique idiopathique de l\u2019enfant. Service des affections de longue dur\u00e9e et accords conventionnels:1\u201322"},{"key":"2310_CR6","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.ki.5001875","volume":"70","author":"K Uhlig","year":"2006","unstructured":"Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, Moist L, Steinberg E, Walker R, Wanner C, Lameire N, Eknoyan G (2006) Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 70:2058\u20132065","journal-title":"Kidney Int"},{"key":"2310_CR7","doi-asserted-by":"crossref","unstructured":"Lombel RM, Hodson E, Gipson D (2012) Treatment of steroid-resistant nephrotic syndrome in children\u2013 new guidelines from KDIGO. Pediatr Nephrol. doi: 10.1007\/s00467-012-2304-8","DOI":"10.1007\/s00467-012-2304-8"},{"key":"2310_CR8","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int, Suppl 2:139\u2013274","DOI":"10.1038\/kisup.2012.9"},{"key":"2310_CR9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schunemann HJ (2008) Going from evidence to recommendations. BMJ 336:1049\u20131051","journal-title":"BMJ"},{"key":"2310_CR10","doi-asserted-by":"crossref","unstructured":"Hodson EM, Willis NS, Craig JC (2007) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev:CD001533","DOI":"10.1002\/14651858.CD001533.pub4"},{"key":"2310_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0031-3955(16)32565-2","volume":"18","author":"GC Arneil","year":"1971","unstructured":"Arneil GC (1971) The nephrotic syndrome. Pediatr Clin North Am 18:547\u2013559","journal-title":"Pediatr Clin North Am"},{"key":"2310_CR12","unstructured":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie (1988) Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 1:380\u2013383"},{"key":"2310_CR13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00467-008-1089-2","volume":"24","author":"J Feber","year":"2009","unstructured":"Feber J, Al-Matrafi J, Farhadi E, Vaillancourt R, Wolfish N (2009) Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent? Pediatr Nephrol 24:1027\u20131031","journal-title":"Pediatr Nephrol"},{"key":"2310_CR14","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00467-011-1961-3","volume":"26","author":"S Saadeh","year":"2011","unstructured":"Saadeh S, Baracco R, Jain A, Kapur G, Mattoo TK, Valentini R (2011) Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? Pediatr Nephrol 26:2167\u20132171","journal-title":"Pediatr Nephrol"},{"key":"2310_CR15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","volume":"57","author":"O Koskimies","year":"1982","unstructured":"Koskimies O, Vilska J, Rapola J, Hallman N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544\u2013548","journal-title":"Arch Dis Child"},{"key":"2310_CR16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776","journal-title":"J Am Soc Nephrol"},{"key":"2310_CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/adc.2007.116079","volume":"93","author":"AS Abeyagunawardena","year":"2008","unstructured":"Abeyagunawardena AS, Trompeter RS (2008) Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child 93:226\u2013228","journal-title":"Arch Dis Child"},{"key":"2310_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.01850310","volume":"6","author":"A Gulati","year":"2011","unstructured":"Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A (2011) Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6:63\u201369","journal-title":"Clin J Am Soc Nephrol"},{"key":"2310_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000045684","volume":"85","author":"TK Mattoo","year":"2000","unstructured":"Mattoo TK, Mahmoud MA (2000) Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. Nephron 85:343\u2013345","journal-title":"Nephron"},{"key":"2310_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/000992288802700807","volume":"27","author":"AY Elzouki","year":"1988","unstructured":"Elzouki AY, Jaiswal OP (1988) Long-term, small-dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. Clin Pediatr (Phila) 27:387\u2013392","journal-title":"Clin Pediatr (Phila)"},{"key":"2310_CR21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00878359","volume":"6","author":"RN Srivastava","year":"1992","unstructured":"Srivastava RN, Vasudev AS, Bagga A, Sunderam KR (1992) Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 6:247\u2013250","journal-title":"Pediatr Nephrol"},{"key":"2310_CR22","doi-asserted-by":"crossref","unstructured":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451\u2013454","DOI":"10.1056\/NEJM198202253060803"},{"key":"2310_CR23","doi-asserted-by":"crossref","unstructured":"Hodson EM, Willis NS, Craig JC (2008) Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev:CD002290","DOI":"10.1002\/14651858.CD002290.pub3"},{"key":"2310_CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004670000523","volume":"16","author":"K Latta","year":"2001","unstructured":"Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271\u2013282","journal-title":"Pediatr Nephrol"},{"key":"2310_CR25","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/jama.1971.03190120030006","volume":"217","author":"DG Miller","year":"1971","unstructured":"Miller DG (1971) Alkylating agents and human spermatogenesis. JAMA 217:1662\u20131665","journal-title":"JAMA"},{"key":"2310_CR26","first-page":"347","volume":"62","author":"JF Wetzels","year":"2004","unstructured":"Wetzels JF (2004) Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis? Neth J Med 62:347\u2013352","journal-title":"Neth J Med"},{"key":"2310_CR27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM198004243021701","volume":"302","author":"SA Williams","year":"1980","unstructured":"Williams SA, Makker SP, Ingelfinger JR, Grupe WE (1980) Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929\u2013933","journal-title":"N Engl J Med"},{"key":"2310_CR28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00467-003-1404-x","volume":"19","author":"N Prasad","year":"2004","unstructured":"Prasad N, Gulati S, Sharma RK, Singh U, Ahmed M (2004) Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 19:494\u2013498","journal-title":"Pediatr Nephrol"},{"key":"2310_CR29","first-page":"1535","volume":"21","author":"AS Abeyagunawardena","year":"2006","unstructured":"Abeyagunawardena AS, Trompeter RS (2006) Intravenous pulsed versus oral cyclophosphamide therapy in steroid dependant nephrotic syndrome. Pediatr Nephrol 21:1535","journal-title":"Pediatr Nephrol"},{"key":"2310_CR30","first-page":"289","volume":"4","author":"R Weiss","year":"1993","unstructured":"Weiss R (1993) Randomized double-blind placebo controlled, multi-center trial of levamisole for children with frequently relapsing\/steroid-dependent nephrotic syndrome. J Am Soc Nephrol 4:289","journal-title":"J Am Soc Nephrol"},{"key":"2310_CR31","doi-asserted-by":"crossref","first-page":"c137","DOI":"10.1159\/000079172","volume":"97","author":"LS Fu","year":"2004","unstructured":"Fu LS, Shien CY, Chi CS (2004) Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and\/or steroid dependency: comparison of daily and every-other-day usage. Nephron Clin Pract 97:c137\u2013c141","journal-title":"Nephron Clin Pract"},{"key":"2310_CR32","first-page":"35","volume":"16","author":"F Hafeez","year":"2006","unstructured":"Hafeez F, Ahmed TM, Samina U (2006) Levamisole in steroid-dependent and frequently relapsing nephrotic syndrome. J Coll Physicians Surg Pak 16:35\u201337","journal-title":"J Coll Physicians Surg Pak"},{"key":"2310_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2007-1023943","volume":"123","author":"MJ Kemper","year":"1998","unstructured":"Kemper MJ, Amon O, Timmermann K, Altrogge H, Muller-Wiefel DE (1998) The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children. Dtsch Med Wochenschr 123:239\u2013243","journal-title":"Dtsch Med Wochenschr"},{"key":"2310_CR34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00865500","volume":"8","author":"JB Palcoux","year":"1994","unstructured":"Palcoux JB, Niaudet P, Goumy P (1994) Side effects of levamisole in children with nephrosis. Pediatr Nephrol 8:263\u2013264","journal-title":"Pediatr Nephrol"},{"key":"2310_CR35","first-page":"1682","volume":"26","author":"MP Gruppen","year":"2011","unstructured":"Gruppen MP, Bouts AH, Davin JC (2011) The levamisole study in steroid-sensitive idiopathic nephrotic syndrome (SSINS). Pediatr Nephrol 26:1682","journal-title":"Pediatr Nephrol"},{"key":"2310_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00856817","volume":"6","author":"P Niaudet","year":"1992","unstructured":"Niaudet P (1992) Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 6:1\u20133","journal-title":"Pediatr Nephrol"},{"key":"2310_CR37","first-page":"1326","volume":"8","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, Bettinelli A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Delia Casa-Alberighi O (1993) Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326\u20131332","journal-title":"Nephrol Dial Transplant"},{"key":"2310_CR38","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","volume":"20","author":"A El-Husseini","year":"2005","unstructured":"El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M (2005) Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol Dial Transplant 20:2433\u20132438","journal-title":"Nephrol Dial Transplant"},{"key":"2310_CR39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00856511","volume":"8","author":"SA Hulton","year":"1994","unstructured":"Hulton SA, Neuhaus TJ, Dillon MJ, Barratt TM (1994) Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood. Pediatr Nephrol 8:401\u2013403","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"2310_CR40","first-page":"S31","volume":"35","author":"P Niaudet","year":"1991","unstructured":"Niaudet P, Broyer M, Habib R (1991) Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 35(Suppl 1):S31\u2013S36","journal-title":"Clin Nephrol"},{"key":"2310_CR41","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/ndt\/gfi274","volume":"21","author":"MD Sinha","year":"2006","unstructured":"Sinha MD, MacLeod R, Rigby E, Clark AG (2006) Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant 21:1848\u20131854","journal-title":"Nephrol Dial Transplant"},{"key":"2310_CR42","doi-asserted-by":"crossref","unstructured":"Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, Fu H, Du L, Liu A (2012) Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol. doi: 10.1007\/s00467-012-2228-3","DOI":"10.1007\/s00467-012-2228-3"},{"key":"2310_CR43","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/ndt\/gfl222","volume":"21","author":"J Dotsch","year":"2006","unstructured":"Dotsch J, Dittrich K, Plank C, Rascher W (2006) Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A? Nephrol Dial Transplant 21:1761\u20131763","journal-title":"Nephrol Dial Transplant"},{"key":"2310_CR44","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/ndt\/gfq813","volume":"26","author":"C Morgan","year":"2011","unstructured":"Morgan C, Sis B, Pinsk M, Yiu V (2011) Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome. Nephrol Dial Transplant 26:2860\u20132865","journal-title":"Nephrol Dial Transplant"},{"key":"2310_CR45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","volume":"4","author":"O Heisel","year":"2004","unstructured":"Heisel O, Heisel R, Balshaw R, Keown P (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 4:583\u2013595","journal-title":"Am J Transplant"},{"key":"2310_CR46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00228-005-0064-0","volume":"62","author":"A El-Husseini","year":"2006","unstructured":"El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Sheashaa H, Sabry A, Hassan N, Sayed-Ahmad N, Sobh M (2006) Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome. Eur J Clin Pharmacol 62:3\u20138","journal-title":"Eur J Clin Pharmacol"},{"key":"2310_CR47","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","volume":"61","author":"K Iijima","year":"2002","unstructured":"Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801\u20131805","journal-title":"Kidney Int"},{"key":"2310_CR48","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ki.2008.24","volume":"73","author":"K Ishikura","year":"2008","unstructured":"Ishikura K, Ikeda M, Hattori S, Yoshikawa N, Sasaki S, Iijima K, Nakanishi K, Yata N, Honda M (2008) Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int 73:1167\u20131173","journal-title":"Kidney Int"},{"key":"2310_CR49","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ndt\/gfh803","volume":"20","author":"G Filler","year":"2005","unstructured":"Filler G (2005) How should microemulsified cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored? Nephrol Dial Transplant 20:1032\u20131034","journal-title":"Nephrol Dial Transplant"},{"key":"2310_CR50","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","volume":"23","author":"EM Dorresteijn","year":"2008","unstructured":"Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ (2008) Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 23:2013\u20132020","journal-title":"Pediatr Nephrol"},{"key":"2310_CR51","first-page":"1579","volume":"26","author":"J Gellerman","year":"2011","unstructured":"Gellerman J, Ouerfeld U (2011) Frequently relapsing steroid-sensitive nephrotic syndrome (SSNS) in children and adolescents: treatment with mycophenolate mofetil (MMF) vs. cyclosporine (CsA). Pediatr Nephrol 26:1579","journal-title":"Pediatr Nephrol"},{"key":"2310_CR52","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","volume":"22","author":"K Afzal","year":"2007","unstructured":"Afzal K, Bagga A, Menon S, Hari P, Jordan SC (2007) Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome. Pediatr Nephrol 22:2059\u20132065","journal-title":"Pediatr Nephrol"},{"key":"2310_CR53","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","volume":"6","author":"P Ravani","year":"2011","unstructured":"Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, Belingheri M, Scolari F, Ghiggeri GM (2011) Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6:1308\u20131315","journal-title":"Clin J Am Soc Nephrol"},{"key":"2310_CR54","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"2310_CR55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00467-009-1376-6","volume":"25","author":"A Prytula","year":"2010","unstructured":"Prytula A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, Taylor M, Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K (2010) Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 25:461\u2013468","journal-title":"Pediatr Nephrol"},{"key":"2310_CR56","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00467-009-1195-9","volume":"24","author":"MC Chaumais","year":"2009","unstructured":"Chaumais MC, Garnier A, Chalard F, Peuchmaur M, Dauger S, Jacqz-Agrain E, Deschenes G (2009) Fatal pulmonary fibrosis after rituximab administration. Pediatr Nephrol 24:1753\u20131755","journal-title":"Pediatr Nephrol"},{"key":"2310_CR57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","volume":"58","author":"K Yoshioka","year":"2000","unstructured":"Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S (2000) A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 58:317\u2013324","journal-title":"Kidney Int"},{"key":"2310_CR58","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00467-005-1943-4","volume":"20","author":"A Donia","year":"2005","unstructured":"Donia A, Ammar HM, El Agroudy A, Moustafa F, Sobh M (2005) Long-term results of two unconventional agents in steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:1420\u20131425","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2310-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2310-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T22:09:01Z","timestamp":1643494141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2310-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2310-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,3]]}}}